PMID- 9536945 OWN - NLM STAT- MEDLINE DCOM- 19980420 LR - 20190501 IS - 0017-5749 (Print) IS - 1458-3288 (Electronic) IS - 0017-5749 (Linking) VI - 42 IP - 2 DP - 1998 Feb TI - Interferon gamma induces differential upregulation of alpha and beta chemokine secretion in colonic epithelial cell lines. PG - 208-13 AB - BACKGROUND: Production of chemoattractant factors by the intestinal epithelium may contribute to mucosal infiltration by inflammatory cells in inflammatory bowel disease. Secretion of the alpha chemokine interleukin 8 (IL-8), a neutrophil chemoattractant, has been widely studied, but little is known about epithelial secretion of beta chemokines, which are preferentially involved in recruiting monocytes. AIMS: To investigate the profiles of alpha and beta chemokine secretion in colonic cell lines and their differential modulation by interferon gamma (IFN-gamma), a product of activated T lymphocytes and natural killer cells. METHODS AND RESULTS: HT29-19A, a model of the CT secretory crypt cell, exhibited a parallel secretion of the alpha chemokines IL-8 and GRO alpha, which could be markedly upregulated by tumour necrosis factor alpha (TNF-alpha) and IL-1 beta. These cells showed no significant expression of the beta chemokines RANTES (regulated upon activation T cell expressed and secreted), MIP-1 alpha (macrophage inflammatory protein 1 alpha), and MCP-1 (monocyte chemotactic protein 1) under these conditions, but IFN-gamma in combination with TNF-alpha caused a dose dependent induction of RANTES and MCP-1 secretion. This was accompanied by a marked increase of RANTES mRNA. In contrast, IFN-gamma had no significant effect on TNF-alpha stimulated IL-8 secretion. Caco-2 cells, with features more typical of villus absorptive cells, were relatively poor secretors of alpha chemokines but secreted high levels of MCP-1 in response to IL-1 beta. IFN-gamma did not influence alpha or beta chemokine secretion in these cells. CONCLUSIONS: These studies suggest that intestinal epithelial cells may produce chemokines capable of attracting both neutrophils and monocytes. The ability of IFN-gamma to activate the expression of beta chemokines preferentially could facilitate the development of chronic inflammatory infiltrates. FAU - Warhurst, A C AU - Warhurst AC AD - Department of Surgery, Hope Hospital, Salford, UK. FAU - Hopkins, S J AU - Hopkins SJ FAU - Warhurst, G AU - Warhurst G LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - England TA - Gut JT - Gut JID - 2985108R RN - 0 (CXCL1 protein, human) RN - 0 (Chemokine CCL2) RN - 0 (Chemokine CCL5) RN - 0 (Chemokine CXCL1) RN - 0 (Chemokines) RN - 0 (Chemokines, CXC) RN - 0 (Chemotactic Factors) RN - 0 (Growth Inhibitors) RN - 0 (Growth Substances) RN - 0 (Intercellular Signaling Peptides and Proteins) RN - 0 (Interleukin-8) RN - 0 (RNA, Messenger) RN - 0 (Tumor Necrosis Factor-alpha) RN - 82115-62-6 (Interferon-gamma) SB - IM MH - Caco-2 Cells/*drug effects/metabolism MH - Chemokine CCL2/metabolism MH - Chemokine CCL5/genetics/metabolism MH - Chemokine CXCL1 MH - Chemokines/*metabolism MH - *Chemokines, CXC MH - Chemotactic Factors/metabolism MH - Dose-Response Relationship, Drug MH - Drug Synergism MH - Gene Expression MH - Growth Inhibitors/metabolism MH - Growth Substances/metabolism MH - HT29 Cells/*drug effects/metabolism MH - Humans MH - Immunoenzyme Techniques MH - *Intercellular Signaling Peptides and Proteins MH - Interferon-gamma/*pharmacology MH - Interleukin-8/metabolism MH - RNA, Messenger/analysis MH - Stimulation, Chemical MH - Tumor Necrosis Factor-alpha/pharmacology PMC - PMC1726988 EDAT- 1998/04/16 00:00 MHDA- 1998/04/16 00:01 PMCR- 2001/02/01 CRDT- 1998/04/16 00:00 PHST- 1998/04/16 00:00 [pubmed] PHST- 1998/04/16 00:01 [medline] PHST- 1998/04/16 00:00 [entrez] PHST- 2001/02/01 00:00 [pmc-release] AID - 10.1136/gut.42.2.208 [doi] PST - ppublish SO - Gut. 1998 Feb;42(2):208-13. doi: 10.1136/gut.42.2.208.